Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prem Pais

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
JAMA|January 27, 2005
Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trialShamir R Mehta, Salim Yusuf, Rafael Díaz, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|December 28, 2021
The cost implications of a polypill for primary prevention in the TIPS-3 trialAndre Lamy, Wesley Tong, Philip Joseph, et al.
American Heart Journal|July 3, 2013
Rationale and design of the Primary pREvention strategies at the community level to Promote Adherence of treatments to pREvent cardiovascular diseases trial number (CTRI/2012/09/002981)Farah N Fathima, Rajnish Joshi, Twinkle Agrawal, et al.
Eclinicalmedicine|June 6, 2024
Cost effectiveness analysis of a fixed dose combination pill for primary prevention of cardiovascular disease from an individual participant data meta-analysisAndre Lamy, Wesley Tong, Philip Joseph, et al.
JAMA|November 29, 2007
Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarctionRafael Díaz, Abhinav Goyal, Shamir R Mehta, et al.
American Heart Journal|December 3, 2014
Rationale and design of a randomized controlled trial evaluating community health worker-based interventions for the secondary prevention of acute coronary syndromes in India (SPREAD)Deepak Y Kamath, Denis Xavier, Rajeev Gupta, et al.
Blood Pressure. Supplement|February 23, 2012
Effect of fixed dose combinations of metoprolol and amlodipine in essential hypertension: MARS--a randomized controlled trialPadmini Devi, Denis Xavier, Alben Sigamani, et al.
Lancet (London, England)|August 31, 2010
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trialLars Wallentin, Salim Yusuf, Michael D Ezekowitz, et al.
Journal of the American College of Cardiology|January 17, 2009
Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART StudyGanesan Karthikeyan, Koon K Teo, Shofiqul Islam, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 28, 2023
Characteristics, clinical practice patterns, and outcomes of strokes in India: INSPIRE-A multicentre prospective studyDenis Xavier, Robert Murphy, Prem Pais, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
JAMA|January 27, 2005
Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trialShamir R Mehta, Salim Yusuf, Rafael Díaz, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|December 28, 2021
The cost implications of a polypill for primary prevention in the TIPS-3 trialAndre Lamy, Wesley Tong, Philip Joseph, et al.
American Heart Journal|July 3, 2013
Rationale and design of the Primary pREvention strategies at the community level to Promote Adherence of treatments to pREvent cardiovascular diseases trial number (CTRI/2012/09/002981)Farah N Fathima, Rajnish Joshi, Twinkle Agrawal, et al.
Eclinicalmedicine|June 6, 2024
Cost effectiveness analysis of a fixed dose combination pill for primary prevention of cardiovascular disease from an individual participant data meta-analysisAndre Lamy, Wesley Tong, Philip Joseph, et al.
JAMA|November 29, 2007
Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarctionRafael Díaz, Abhinav Goyal, Shamir R Mehta, et al.
American Heart Journal|December 3, 2014
Rationale and design of a randomized controlled trial evaluating community health worker-based interventions for the secondary prevention of acute coronary syndromes in India (SPREAD)Deepak Y Kamath, Denis Xavier, Rajeev Gupta, et al.
Blood Pressure. Supplement|February 23, 2012
Effect of fixed dose combinations of metoprolol and amlodipine in essential hypertension: MARS--a randomized controlled trialPadmini Devi, Denis Xavier, Alben Sigamani, et al.
Lancet (London, England)|August 31, 2010
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trialLars Wallentin, Salim Yusuf, Michael D Ezekowitz, et al.
Journal of the American College of Cardiology|January 17, 2009
Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART StudyGanesan Karthikeyan, Koon K Teo, Shofiqul Islam, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 28, 2023
Characteristics, clinical practice patterns, and outcomes of strokes in India: INSPIRE-A multicentre prospective studyDenis Xavier, Robert Murphy, Prem Pais, et al.
Pageof 11